Sequoia China, HighLight Capital Back $16M Series A Round In US Biotech Start-Up

This Data Is Locked!

This area is available only to Subscribers.

Sequoia Capital China and Chinese healthcare-focused investment firm HighLight Capital have backed a US$16 million series A round of financing in America-based biotechnology company Cullgen... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?